Please assess the completion status of the following clinical trial:

Trial Title: VISIODOL: Validation of the VISIODOL® Scale

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy volunteers~* Subjects aged over 18 / under 60~* Male or female~* Subjects fasting from coffee, tea, Coca-Cola and others stimulants~* Sufficient understanding and cooperation to comply with the study requirements~* Agreed to provide written consent~* Affiliated to the social security~* Subjects with visual impairment (congenital or acquired)~* Subjects with no visual impairment (healthy group)~Exclusion Criteria:~* Subjects under 18 years old~* Administrative and legal criteria (tutorship, curatorship, without social security, in exclusion period of another study)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Healthy volunteer group (Type: ACTIVE_COMPARATOR): male or female healthy volunteers
- Subjects with acquired visual impairment (Type: EXPERIMENTAL): visual acquired disability
- Subjects with congenital visual impairment (Type: EXPERIMENTAL): Visual congenital disability

Based on this trial design, predict the completion outcome and termination type (if applicable).